Spyre Therapeutics (SYRE) Q4 2020 Earnings

18MarExpected
Q1 2020
Q2 2020
Q3 2020
Q4 2020
-14.25
-9.61
-4.98
-0.34

Details

Expected EPS
-0.3429
Actual EPS
-8.75
Surprise EPS
-8.41
Surprise Percent
+2,451.76%

Description

Spyre Therapeutics (SYRE) has reported earnings of -8.75 per share for Q4 2020.

0 Comments

Share your thoughts